Division of Electrophysiology, Department of Cardiovascular Medicine, University of Münster, Münster, Germany.
Clinic of Exotic Pets, Reptiles, Exotic and Feral Birds, University of Hanover, Hanover, Germany.
J Cardiovasc Electrophysiol. 2018 Mar;29(3):471-476. doi: 10.1111/jce.13412. Epub 2018 Jan 22.
A significant antiarrhythmic potential of ryanodine receptor inhibition was reported in experimental studies. The aim of the present study was to assess potential antiarrhythmic effects of dantrolene in an experimental whole-heart model of drug-induced long-QT syndrome (LQTS).
In 12 isolated rabbit hearts, long-QT-2-syndrome was simulated by infusion of erythromycin (300 μM). Twelve rabbit hearts were treated with veratridine (0.5 μM) to mimic long-QT-3-syndrome.
Monophasic action potentials and ECG showed a significant prolongation of QT-interval (+71 ms, P < 0.01) and action potential duration (APD, +43 ms, P < 0.01) after infusion of erythromycin as compared with baseline. Similar results were obtained in veratridine-treated hearts (QT-interval: +43 ms, P < 0.01; APD: +36 ms, P < 0.01). Both erythromycin (+36 ms, P < 0.05) and veratridine (+38 ms) significantly increased dispersion of repolarization. Additional infusion of dantrolene (20 μM) did not significantly alter QT-interval and APD but resulted in a significant reduction of dispersion of repolarization (erythromycin group: -33 ms, P < 0.05; veratridine group: -29 ms, P < 0.05). Lowering of potassium concentration resulted in the occurrence of early afterdepolarizations (EAD) and polymorphic ventricular tachycardia (VT) in 9 of 12 erythromycin-treated hearts (175 episodes) and 8 of 12 veratridine-treated hearts (66 episodes). Additional infusion of dantrolene significantly reduced occurrence of polymorphic VT and resulted in occurrence of EAD and polymorphic VT in 1 of 12 erythromycin-treated hearts (18 episodes) and 1 of 12 veratridine-treated hearts (3 episodes).
Inhibition of the ryanodine receptor by dantrolene significantly reduced occurrence of polymorphic VT in drug-induced LQTS. A significant reduction of spatial dispersion of repolarization represents a major antiarrhythmic mechanism. These results imply that dantrolene may represent a promising antiarrhythmic option in drug-induced LQTS.
已有研究报道,兰尼碱受体抑制具有显著的抗心律失常作用。本研究旨在评估丹曲林钠在药物诱导长 QT 综合征(LQTS)的整体心脏实验模型中的潜在抗心律失常作用。
在 12 个离体兔心中,通过输注红霉素(300μM)模拟长 QT-2 综合征。用藜芦碱(0.5μM)处理 12 个兔心以模拟长 QT-3 综合征。
与基线相比,输注红霉素后单相动作电位和心电图显示 QT 间期显著延长(+71ms,P<0.01)和动作电位时程(APD,+43ms,P<0.01)。在藜芦碱处理的心脏中也得到了类似的结果(QT 间期:+43ms,P<0.01;APD:+36ms,P<0.01)。红霉素(+36ms,P<0.05)和藜芦碱(+38ms)均显著增加复极离散度。另外输注丹曲林钠(20μM)并未显著改变 QT 间期和 APD,但显著降低复极离散度(红霉素组:-33ms,P<0.05;藜芦碱组:-29ms,P<0.05)。降低钾浓度可导致 12 个红霉素处理的心脏中的 9 个(175 个发作)和 12 个藜芦碱处理的心脏中的 8 个(66 个发作)发生早期后除极(EAD)和多形性室性心动过速(VT)。另外输注丹曲林钠可显著减少多形性 VT 的发生,并导致 12 个红霉素处理的心脏中的 1 个(18 个发作)和 12 个藜芦碱处理的心脏中的 1 个(3 个发作)发生 EAD 和多形性 VT。
丹曲林钠抑制兰尼碱受体可显著减少药物诱导的 LQTS 中的多形性 VT 发生。复极离散度的显著降低是主要的抗心律失常机制。这些结果表明,丹曲林钠可能是药物诱导的 LQTS 中有前途的抗心律失常选择。